Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 65 | SFEBES2019 | Next issue

Society for Endocrinology BES 2019

Brighton, United Kingdom
11 Nov 2019 - 13 Nov 2019

Card image cap
Come and exchange knowledge, share experiences and strengthen collaborations across our global community of endocrinologists!

POSTER PRESENTATIONS

Metabolism and Obesity

Sarcopenic phenotypes are associated with an increased risk of type 2 diabetes: findings from the Korean Genome and Epidemiology Study (KoGES)
1The Catholic University of Korea, Seoul, Republic of Korea; 2Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
ea0065p167
Long term impact of sleeve gastrectomy on metabolic parameters in morbidly obese patients
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; 2Elias University Hospital, Bucharest, Romania; 3Ponderas Hospital, Bucharest, Romania
ea0065p168
Intravascular subcutaneous adipose tissue blood flow measured with Doppler ultrasound for experimental medicine studies
1Institute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, UK; 2Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK; 3Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, Netherlands
ea0065p169
Brain derived neurotrophic factor (BDNF) methylation in patients with impaired glucose regulation: implications progression to type 2 diabetes mellitus (T2DM)
1Salford Royal Foundation Trust, Salford, UK; 2The University of Manchester, Manchester, UK; 3High Speciality Regional Hospital of Ixtapaluca, Ixtapaluca, Mexico; 4Sheffield Hallam University, Sheffield, UK
ea0065p176
Endotoxin and adiposity as mediators of down-regulating the BRITE fat phenotype
1University of Warwick, Coventry, UK; 2Nottingham Trent University, Nottingham, UK
ea0065p185
AKR1D1 (5[beta]-reductase) deletion drives hepatic inflammation, fibrosis and tumour development in vivo
1University of Oxford, Oxford, UK; 2Oxford Brookes University, Oxford, UK; 3MRC Harwell Institute, Didcot, UK
ea0065p186
Low B12 is associated with increased de novo synthesis of 'unsafe' fatty acids in the liver
1Division of Metabolic and Vascular Health, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, Coventry, UK; 2Interdisciplinary Science and Technology Centre, School of Science and Technology, Nottingham Trent University, Clifton, Nottingham, UK; 3Diabetes Centre, George Eliot Hospital NHS Trust College Street, Nuneaton, Warwickshire, Nuneaton, UK
ea0065p187
Insulin signalling in kidney podocytes: an information theoretic approach
Bristol Renal, Department of Translational Health, Bristol Medical School, University of Bristol, Bristol, UK
ea0065p188
The FreeStyle libre flash glucose monitoring system: how it has improved glycaemic control for people with type 1 diabetes (T1DM) in Eastern Cheshire, UK
1New Cross Hospital, Wolverhampton, UK; 2Salford Royal Hospital, Salford, UK; 3University of Manchester, Manchester, UK; 4Watersgreen Medical Centre, Macclesfield, UK
ea0065p189
Androgen receptor reduced sensitivity is associated with increased mortality, poor glycemic control and BMI in men with type 2 diabetes - a 14-year follow up study
1Salford Royal Hospital, Salford, UK; 2University of Manchester, Manchester, UK; 3Isfahan University of Medical Sciences, Isfahan, Islamic Republic of Iran; 4Walsall Manor Hospital, Walsall, UK; 5University of Liverpool, Liverpool, UK; 6High Speciality Regional Hospital of Ixtapaluca, Mexico City, Mexico; 7Heartlands Hospital Birmingham, Birmingham, UK; 8University of Sheffield, Sheffield, United Kingtom
ea0065p190
Male testosterone levels and laboratory practice: a need for a standardised approach to measurement and reporting
1Department of Clinical Biochemistry, Black Country Pathology Services, Walsall Manor Hospital, Walsall, UK; 2The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK; 3Department of Clinical Biochemistry, Bristol Royal Infirmary, Bristol, UK; 4School of Health and Life Sciences, Aston University, Birmingham, UK; 5Birmingham Quality (UK NEQAS), University Hospitals NHS Foundation Trust, Birmingham, UK; 6Department of Endocrinology and Diabetes, Salford Royal Hospital, Manchester, UK; 7Department of Clinical Biochemistry, University Hospitals Birmingham NHS Foundation Trust, Sutton Coldfield, UK; 8Department of Clinical Biochemistry, University Hospitals of North Midlands/ Institute of Science and Technology, Keele University / Faculty of Health Sciences, Staffordshire University, Staffordshire, UK; 9College of Engineering, Design and Physical Sciences, Brunel University, London, UK
ea0065p191
Lipoprotein(a) as a predictive biomarker for subclinical coronary atherosclerosis
1Imperial College London, London, UK; 2Changi General Hospital, Singapore; 3Imperial College Healthcare NHS Trust, London, UK
ea0065p192
Immature [beta]-cells are required for normal islet function and insulin release
1Institute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, UK; 2Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK; 3Institute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Neuherberg, Germany; 4Section of Cell Biology and Functional Genomics, Imperial College London, London, UK; 5Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medical College, New York, USA
ea0065p197
Systemic and femoral adipose tissue-specific nontargeted plasma metabolome during acute hypercortisolaemia
1Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK; 2Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK; 3School of Biosciences, University of Birmingham, Birmingham, UK; 4Phenome Centre Birmingham, University of Birmingham, Birmingham, UK
ea0065p199
A role for kisspeptin in long-term islet function in females
1King’s College London, London, UK; 2University of Oxford, Oxford, UK
ea0065p200
Vitamin D-binding protein is required for the maintenance of [alpha]-cell identity and function
1Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK; 2Oxford Centre for Diabetes, University of Oxford, Oxford, UK; 3Institute of Biomedical and Clinical Science, Medical School, University of Exeter, Exeter, UK; 4Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
ea0065p201
Endoplasmic reticulum stress directly impacts mitochondrial function in human adipocytes
1Warwick University, Warwick, UK; 2Nottingham Trent University, Nottingham, UK
ea0065p202
The track-pump study
Imperial College Healthcare NHS Trust, London, UK
ea0065p203
Visfatin and resistin as predictors of poor pain outcome in total hip and knee joint replacement in patients with osteoarthritis
1University of Birmingham, Birmingham, UK; 2The Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham, UK
ea0065p207
Assessment of cardiovascular disease risk in subjects with pre-diabetes
1Belgrade School of Medicine and Zvezdara University Medical Center, Belgrade, Serbia; 2Cardiovascular Institute Dedinje, Belgrade, Serbia
ea0065p208
Glycated haemoglobin and obstetric outcomes among patients with gestational diabetes mellitus: a single center study
1Cadiocare Cardiovascular Hospital, Abuja, Nigeria; 2Limi Hospital, Abuja, Nigeria
ea0065p211
Hypoglycaemia screen (hypopak) quality improvement audit
1Regional Endocrine Laboratory, Belfast Health and Social Care Trust, Belfast, UK; 2Paediatric Endocrinology and Diabetes Unit, Royal Belfast Hospital for Sick Children, Belfast Health and Social Care Trust, Belfast, UK; 3Regional Metabolic Laboratory, Belfast Health and Social Care Trust, Belfast, UK; 4Paediatric Metabolic Unit, Royal Belfast Hospital for Sick Children, Belfast Health and Social Care Trust, Belfast, UK
ea0065p214
Predicting mortality in both diabetes and open-source clinical datasets from free text entries using machine learning (natural language processing)
1Diabetes Centre, Gartnavel General Hospital, Glasgow, UK; 2Redstar Consulting, Glasgow, UK; 3Tactuum Ltd, Glasgow, UK; 4Scottish Government Digital Health and Care Division, Edinburgh, UK
ea0065p219
A digital lifestyle programme to support outpatient treatment of type 2 diabetes: a randomised controlled trial
1Akureyri Hospital, Akureyri, Iceland; 2University of Akureyri, Akureyri, Iceland; 3Uppsala University, Uppsala, Sweden
ea0065p221
FSH levels are adversely associated with markers of regional adiposity in postmenopausal women
12nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Athens, Greece; 2Hormonal and Biochemical Laboratory, National and Kapodistrian Univeristy of Athens, Aretaieio Hospital, Athens, Greece
ea0065p222
Regulation and role of MiR-125b in [beta]-cells
1Imperial College London, London, UK; 2University of Pisa, Pisa, Italy; 3University of Alberta, Edmonton, Canada; 4Vita-Salute San Raffaele, Milan, Italy; 5Nestle Institute of Health Sciences, Lausanne, Swaziland; 6Astrazeneca, Cambridge, UK
ea0065p224
Steroid deconjugation by helix pomatia - can we overcome snail speed?
1Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK; 2KuraBiotec, Puerto Vara, Chile; 3Children’s Hospital and Research Center at Oakland, Oakland, USA
ea0065p229
Acute changes in steroid biosynthesis in patients following severe trauma: the golden hour study
1Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK; 2NIHR Surgical Reconstruction and Microbiology Research Centre, University Hospital Birmingham, Birmingham, UK; 3Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
ea0065p230
Mammary adipose tissue steroid activation and its relevance for breast cancer prognosis
1CRCHU-UL, Quebec, Canada; 2IUCPQ, Quebec, Canada; 3BHF/CVS, QMRI, U of Edinburgh, Edinburgh, UK; 4ICAMS, U of Glasgow, Glasgow, UK; 5MS Core, Edinburgh CRF, Edinburgh, UK; 6SIPBS, U of Strathclyde, Glasgow, UK; 7IGM, Newcastle University, Newcastle, UK
ea0065p231
Anti thrombin activity in newly diagnosed Type 2 diabetes subjects in a Tertiary Hospital in Calabar, Nigeria
1University of Calabar, Calabar, Nigeria; 2University of Calabar Teaching Hospitalal, Calabar, Nigeria
ea0065p232
L-Phenylalanine simulates the secretion of pancreatic hormones via vagal CaSR
1Imperial College, London, UK; 2Kings College, London, UK; 3University of Auckland, Auckland, New Zealand; 4University of California, San Francisco, USA
ea0065p233
Adhesion G-protein coupled receptors as novel players in islet development
1King’s College London, London, UK; 2Children’s Hospital and Harvard Medical School, Boston, USA
ea0065p234
Obesity induces cardiac hypertrophy without functional or fibrotic alterations
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA; 2Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK; 3Instituto de Investigación en Ciencias Odontológicas, Facultad Odontología, Universidad de Chile, Santiago, Chile; 4Advanced Center for Chronic Diseases (ACCDiS), Facultad Ciencias Quimicas y Farmaceuticas & Facultad Medicina, Santiago, Chile; 5Department of Internal Medicine and Molecular Biology, University of Texas Southwestern Medical Center, Dallas, USA
ea0065p237
Weight loss and change in obesity related comorbidities in patients undergoing laparoscopic adjustable gastric banding at UHCW between 2009 and 2012
1Department of Endocrinology, Diabetes and Metabolism – WISDEM Centre, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK; 2University of Warwick Medical School, Clinical Sciences Research Laboratories, Coventry, UK
ea0065p239
Safe use of variable rate intravenous insulin infusion: a trust wide audit
West Suffolk NHS Foundation Trust UK, Bury St Edmunds, UK
ea0065p240
Investigating the role of microRNA-7 in pancreatic islet development
1MRC London Institute of Medical Sciences (LMS), London, UK; 2Imperial College London, London, UK
ea0065p241
Glucocorticoid treatment is associated with dose-dependent effects in healthy male volunteers
1Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and NIHR Oxford Biomedical Research Centre, Churchill Hospital, University of Oxford, Oxford, UK; 2Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, Rome, Italy
ea0065p242
Mass spectrometric characterisation of circulating proinsulin-derived peptides in insulin autoimmune syndrome
1Cambridge University Hospitals, NHS Foundation Trust, Cambridge, UK; 2University of Cambridge Metabolic Research Laboratories, Cambridge, UK; 3National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK; 4Centre for Cardiovascular Science, Edinburgh, UK
ea0065p243
Glycaemic control in patients with diabetes mellitus in a Tertiary Hospital in South-West, Nigeria
1Obafemi Awolowo University Teaching Hospital Complex, Ile Ife, Nigeria; 2Obafemi Awolowo University, Ile Ife, Nigeria
ea0065p245
Audit on initial investigation and management of hyponatraemia in inpatients
1West Suffolk NHS Foundation Trust, Bury St Edmunds, UK; 2University of Gothenburg, Sweden
ea0065p247
Using problem-based learning (PBL) to engage undergraduate medical students in endocrinology at Edinburgh Medical School
1Medical Education, University of Edinburgh Medical School, Edinburgh, EH16 4SB, UK; 2Division of Health Sciences, University of Edinburgh Medical School, Edinburgh, EH16 4SB, UK
ea0065p248
'H' syndrome; a rare case with novel symptoms
Father Muller Medical College, Mangalore, India
ea0065p249
Molecular interactions of cashew leaf (Anacardium occidentale) derived compounds with anti-diabetic targets: in silico and in vivo studies
1Federal University of Technology, Akure, Akure, Nigeria; 2Centre for Biocomputing and Drug Development, Adekunle Ajasin University, Akungba-Akoko, Nigeria; 3Centre for Genomics Research Initiative, National Biotechnology Agency, Abuja, Nigeria; 4Department of Anatomy, College of Medicine, Ekiti State University, Ado-Ekiti, Nigeria
ea0065p252
Juvenile type 2 diabetes and Klinefelter syndrome
Queen Elizabeth University Hospital, Glasgow, UK
ea0065p253
Ten years type 2 diabetes risks among doctors in Ondo State, South West Nigeria
1University of Medical Science Teaching Hospital Complex, Akure, Nigeria; 2University of Medical Science Teaching Hospital Complex, Ondo, Nigeria; 3College of Health Science, Bayero University, Kano, Nigeria; 4Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Nigeria
ea0065p255
Diabetic lipemia − acute pancreatitis and new diagnosis of diabetes
University Hospital of North Tees, Stockton on Tees, UK
ea0065p256
Life threatening hypoglycaemia associated with illicit benzodiazepines
1Department of Diabetes, Endocrinology and Clinical Pharmacology, Glasgow Royal Infirmary, Glasgow, UK; 2Emergency Department, Glasgow Royal Infirmary, Glasgow, UK
ea0065p257
Severe peri-partum hyponatraemia: is oxytocin always the culprit?
West Suffolk NHS Foundation Trust, Bury St Edmunds, UK
ea0065p258
Diabetes-related knowledge, attitude and practice among patients attending a Tertiary Hospital in Kano, Northwestern Nigeria
1Muhammad Abdullahi Wase Specialist Hospital, Kano, Nigeria; 2State Specialist Hospital, AKURE, Nigeria
ea0065p260
BMI concordance in the United Arab Emirates (UAE): a study of 200 twin pairs
Imperial College London Diabetes Center, Abu Dhabi, UAE
ea0065p263
Emphysematous pyelonephritis − medical management, a viable option
Department of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria
ea0065p265
Cushing's or not − a diagnostic dilemma
Plymouth Hospital NHS Trust, Plymouth, UK
ea0065p266